Desh Rakshak Aushdhalaya Share Price Today | Stock Price & Desh Rakshak Aushdhalaya Share Screener
Track the current Desh Rakshak Aushdhalaya share price and stock price live with TickJournal's free stock screener. Track Desh Rakshak Aushdhalaya marketcap in USD to gauge the company's total market size. Use the Desh Rakshak Aushdhalaya stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Desh Rakshak Aushdhalaya opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹7 and net income of ₹1, with EBITDA of ₹1, an operating margin of 22.0% and a profit margin of 14.3%.
Desh Rakshak Aushdhalaya Share Price Chart
Track the current stock price of Desh Rakshak Aushdhalaya with an interactive chart. Analyse DESHRAK share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Desh Rakshak Aushdhalaya stock quote in one place.
Desh Rakshak Aushdhalaya Company Profile - Fundamental Screener
Screen Desh Rakshak Aushdhalaya company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DESHRAK shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE971E01016.
Company Details
Classification
Identifiers and Leadership
Desh Rakshak Aushdhalaya Balance Sheet Screener
Screen DESHRAK balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹21, up from ₹18 in 2025.
Latest statistics put total assets at ₹21 and shareholder funds at ₹13, with a leverage ratio of 0.25.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 21 | 18 | 16 | 16 | 16 | 15 | 12 | 11 | 11 | 10 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 8 | 8 | 8 | 8 | 8 | 7 | 5 | 4 | 4 | 4 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 3 | 3 | 4 | 4 | 3 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 13 | 10 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 7 |
| Share Capital | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 7 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 3 |
Desh Rakshak Aushdhalaya Income Statement Screener - Profit & Revenue Analysis
Screen Desh Rakshak Aushdhalaya income statement and profit fundamentals. Analyze DESHRAK quarterly results. Desh Rakshak Aushdhalaya reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹7 and net profit was ₹1, equal to earnings per unit of ₹1.10, at an operating margin of 22%.
In that period expenses were ₹6, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹7 and net profit of ₹1.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 7 | 7 | 6 | 6 | 6 | 6 | 7 | 5 | 6 | 5 | 5 | 5 | 5 |
| Expenses | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 4 | 5 | 4 | 4 | 4 | 4 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 22.00% | 20.00% | 20.00% | 21.00% | 21.00% | 19.00% | 14.00% | 15.00% | 14.00% | 14.00% | 13.00% | 14.00% | 14.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 1.10 | 0.99 | 1.07 | 0.96 | 0.91 | 1.08 | 0.95 | 0.69 | 0.76 | 0.64 | 0.63 | 0.00 | 0.05 |
Desh Rakshak Aushdhalaya Cash Flow Screener - Liquidity Fundamentals
Screen DESHRAK cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹1.
Over the same period, investing activities used ₹2 and financing activities provided ₹3.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -1 | 0 | 2 | 0 | 0 | 1 | 1 | -1 | 0 | 0 |
| Investing Activities | -2 | 0 | 0 | -1 | -2 | -1 | -1 | 0 | 0 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | 3 | 0 | -1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
Desh Rakshak Aushdhalaya Shareholding Pattern Screener
See Desh Rakshak Aushdhalaya shareholding pattern with promoter, FII, and DII holdings. Check Desh Rakshak Aushdhalaya promoter holding and ownership changes for DESHRAK on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Sept, promoters held 50.03%, foreign institutions 0.00%, domestic institutions 0.00% and the public 49.84%, spread across 2,392 shareholders.
The shareholder count was 2,392 in 2026-Sept, compared with 2,391 in 2026-Jun.
| Item | 2026-Sept | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 50.03% | 50.03% | 50.03% | 50.03% | 50.07% | 50.07% | 64.28% | 64.28% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 49.84% | 49.84% | 49.83% | 49.84% | 49.84% | 49.84% | 35.64% | 35.65% |
| Other Holding | 0.14% | 0.14% | 0.14% | 0.14% | 0.09% | 0.09% | 0.07% | 0.06% |
| Shareholder Count | 2,392 | 2,391 | 2,393 | 2,411 | 2,429 | 2,428 | 2,353 | 2,345 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Desh Rakshak Aushdhalaya. Desh Rakshak Aushdhalaya dividend yield can be compared with peers and other stocks in the market.
Desh Rakshak Aushdhalaya Stock Index Membership - Nifty & Sensex
See which indices include Desh Rakshak Aushdhalaya stock. Check DESHRAK index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Desh Rakshak Aushdhalaya Market Events Screener - Corporate Actions
Get Desh Rakshak Aushdhalaya corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Desh Rakshak Aushdhalaya stock events that may affect DESHRAK share price, along with derivatives, futures and options activity and sector gainers.
14 corporate actions are listed, the most recent entry being Annual General Meeting dated December 30, 2026, with a record date of December 30, 2026.
It is followed by Quarterly Result Announcement dated November 14, 2026 and Annual General Meeting dated September 25, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-30 | 2026-12-30 | Annual General Meeting | NA | -9.09% |
| 2026-11-14 | 2026-11-14 | Quarterly Result Announcement | NA | -4.08% |
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | 0.00% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -3.74% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 15.74% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -9.52% |
| 2025-12-06 | 2025-12-06 | Quarterly Result Announcement | NA | -4.86% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 4.75% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.95% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.99% |
| 2025-05-29 | 2025-05-29 | Extraordinary General Meeting | NA | 12.83% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | 27.53% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.00% |
Desh Rakshak Aushdhalaya Competitors Screener - Peer Stocks Comparison
Screen DESHRAK competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 448,076 | 41.10 | 61,674 | 12.69% | 11,565 | 59.98 |
| Divis Laboratories | 294,139 | 90.70 | 11,067 | 13.95% | 2,568 | 67.88 |
| Torrent Pharmaceuticals | 178,438 | 84.50 | 13,886 | 20.34% | 2,138 | 49.31 |
| Laurus Labs | 119,949 | 98.10 | 6,868 | 22.01% | 890 | 49.19 |
| Zydus Life Science | 118,902 | 27.60 | 27,658 | 17.64% | 5,026 | 52.87 |
| Dr Reddys Laboratories | 115,011 | 41.70 | 35,059 | 3.90% | 4,158 | 69.34 |
| Cipla | 112,656 | 39.40 | 29,045 | 2.24% | 3,870 | 55.82 |
| Mankind Pharma | 108,490 | 48.40 | 14,636 | 14.85% | 1,938 | 63.62 |
| Aurobindo Pharma | 103,223 | 26.40 | 34,145 | 5.56% | 3,503 | 60.38 |
| Lupin | 90,393 | 17.30 | 29,039 | 26.75% | 5,356 | 44.23 |
Desh Rakshak Aushdhalaya Company Announcements - News & Reports Screener
Screen DESHRAK latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 19, 2026.
The next most recent announcements are dated November 19, 2026 and November 19, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-11-19 | Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 30Th September 2026 | - |
| 2026-11-19 | Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 30Th September 2026 | - |
| 2026-11-18 | Statement Of No Deviation(S) Or Variation(S) In The Use Of Proceeds Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations). | - |
| 2026-11-18 | Statement Of No Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-11-18 | Intimation Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-11-18 | Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 As Per Regulation 33 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-11-18 | Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Para A Of Part A Of Schedule III And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-11-15 | Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-25 | Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-25 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-01 | Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-27 | Intimation Regarding Book Closure | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 24.20 and the P/B ratio is 1.03, with earnings per unit of ₹0.99. Market capitalisation stands at ₹13.40 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.